nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2A6—Bupropion—obesity	0.0652	0.113	CbGbCtD
Buprenorphine—CYP3A7—Cimetidine—obesity	0.0327	0.0565	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0327	0.0565	CbGbCtD
Buprenorphine—CYP2C8—Bupropion—obesity	0.0321	0.0555	CbGbCtD
Buprenorphine—CYP1A2—Phentermine—obesity	0.0293	0.0505	CbGbCtD
Buprenorphine—CYP1A2—Phenylpropanolamine—obesity	0.0279	0.0482	CbGbCtD
Buprenorphine—CYP2C9—Phentermine—obesity	0.0264	0.0455	CbGbCtD
Buprenorphine—CYP1A2—Bupropion—obesity	0.0249	0.043	CbGbCtD
Buprenorphine—CYP3A5—Cimetidine—obesity	0.0245	0.0424	CbGbCtD
Buprenorphine—CYP2D6—Phentermine—obesity	0.0241	0.0416	CbGbCtD
Buprenorphine—CYP2C8—Cimetidine—obesity	0.0236	0.0407	CbGbCtD
Buprenorphine—CYP2C9—Bupropion—obesity	0.0224	0.0387	CbGbCtD
Buprenorphine—CYP2D6—Bupropion—obesity	0.0205	0.0354	CbGbCtD
Buprenorphine—CYP3A4—Sibutramine—obesity	0.0202	0.0349	CbGbCtD
Buprenorphine—CYP2C19—Cimetidine—obesity	0.0198	0.0342	CbGbCtD
Buprenorphine—CYP2D6—Methamphetamine—obesity	0.0193	0.0333	CbGbCtD
Buprenorphine—CYP1A2—Cimetidine—obesity	0.0183	0.0315	CbGbCtD
Buprenorphine—CYP2C9—Cimetidine—obesity	0.0165	0.0284	CbGbCtD
Buprenorphine—ABCB1—Cimetidine—obesity	0.016	0.0276	CbGbCtD
Buprenorphine—CYP3A4—Benzphetamine—obesity	0.0153	0.0265	CbGbCtD
Buprenorphine—CYP2D6—Cimetidine—obesity	0.015	0.026	CbGbCtD
Buprenorphine—CYP3A4—Bupropion—obesity	0.013	0.0225	CbGbCtD
Buprenorphine—CYP2C19—Topiramate—obesity	0.013	0.0224	CbGbCtD
Buprenorphine—CYP3A4—Orlistat—obesity	0.0106	0.0184	CbGbCtD
Buprenorphine—CYP3A4—Cimetidine—obesity	0.00957	0.0165	CbGbCtD
Buprenorphine—CYP3A4—Topiramate—obesity	0.00626	0.0108	CbGbCtD
Buprenorphine—Naloxone—TLR4—obesity	0.00166	0.712	CrCbGaD
Buprenorphine—OPRL1—adrenal gland—obesity	0.00114	0.0661	CbGeAlD
Buprenorphine—OPRL1—endocrine gland—obesity	0.000993	0.0573	CbGeAlD
Buprenorphine—UGT1A9—digestive system—obesity	0.000783	0.0452	CbGeAlD
Buprenorphine—CYP2C18—digestive system—obesity	0.000684	0.0395	CbGeAlD
Buprenorphine—UGT1A9—endocrine gland—obesity	0.000647	0.0374	CbGeAlD
Buprenorphine—UGT1A9—liver—obesity	0.000583	0.0337	CbGeAlD
Buprenorphine—CYP2C18—endocrine gland—obesity	0.000565	0.0327	CbGeAlD
Buprenorphine—CYP3A7—endocrine gland—obesity	0.000538	0.0311	CbGeAlD
Buprenorphine—CYP2C18—liver—obesity	0.00051	0.0294	CbGeAlD
Buprenorphine—CYP3A7—liver—obesity	0.000485	0.028	CbGeAlD
Buprenorphine—CYP2A6—adipose tissue—obesity	0.00048	0.0277	CbGeAlD
Buprenorphine—Naloxone—ESR1—obesity	0.000465	0.2	CrCbGaD
Buprenorphine—CYP2D6—hindbrain—obesity	0.000436	0.0252	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—liver—obesity	0.000412	0.0238	CbGeAlD
Buprenorphine—CYP3A5—islet of Langerhans—obesity	0.000382	0.022	CbGeAlD
Buprenorphine—CYP1A2—respiratory system—obesity	0.000374	0.0216	CbGeAlD
Buprenorphine—CYP3A5—respiratory system—obesity	0.00036	0.0208	CbGeAlD
Buprenorphine—OPRM1—endocrine gland—obesity	0.000349	0.0201	CbGeAlD
Buprenorphine—CYP2A6—liver—obesity	0.000337	0.0195	CbGeAlD
Buprenorphine—ABCG2—adrenal cortex—obesity	0.000326	0.0188	CbGeAlD
Buprenorphine—CYP2C19—digestive system—obesity	0.000291	0.0168	CbGeAlD
Buprenorphine—CYP2C9—cardiovascular system—obesity	0.000272	0.0157	CbGeAlD
Buprenorphine—CYP2C8—pituitary gland—obesity	0.000271	0.0156	CbGeAlD
Buprenorphine—ABCG2—pituitary gland—obesity	0.000263	0.0152	CbGeAlD
Buprenorphine—ABCG2—adipose tissue—obesity	0.000262	0.0151	CbGeAlD
Buprenorphine—CYP3A5—adipose tissue—obesity	0.000243	0.0141	CbGeAlD
Buprenorphine—CYP2C19—endocrine gland—obesity	0.00024	0.0139	CbGeAlD
Buprenorphine—CYP1A2—digestive system—obesity	0.000238	0.0137	CbGeAlD
Buprenorphine—ABCG2—adrenal gland—obesity	0.000235	0.0136	CbGeAlD
Buprenorphine—CYP3A5—digestive system—obesity	0.000229	0.0132	CbGeAlD
Buprenorphine—CYP2C9—digestive system—obesity	0.000225	0.013	CbGeAlD
Buprenorphine—CYP2C19—liver—obesity	0.000217	0.0125	CbGeAlD
Buprenorphine—CYP2C8—endocrine gland—obesity	0.00021	0.0121	CbGeAlD
Buprenorphine—Naloxone—ALB—obesity	0.000207	0.0889	CrCbGaD
Buprenorphine—ABCB1—islet of Langerhans—obesity	0.000203	0.0117	CbGeAlD
Buprenorphine—CYP1A2—endocrine gland—obesity	0.000196	0.0113	CbGeAlD
Buprenorphine—ABCB1—respiratory system—obesity	0.000191	0.0111	CbGeAlD
Buprenorphine—CYP3A5—endocrine gland—obesity	0.000189	0.0109	CbGeAlD
Buprenorphine—CYP2C8—liver—obesity	0.000189	0.0109	CbGeAlD
Buprenorphine—CYP2C9—endocrine gland—obesity	0.000186	0.0108	CbGeAlD
Buprenorphine—ABCG2—liver—obesity	0.000184	0.0106	CbGeAlD
Buprenorphine—CYP1A2—liver—obesity	0.000177	0.0102	CbGeAlD
Buprenorphine—Chest pain—Orlistat—obesity	0.000175	0.000768	CcSEcCtD
Buprenorphine—Myalgia—Orlistat—obesity	0.000175	0.000768	CcSEcCtD
Buprenorphine—Loss of consciousness—Sibutramine—obesity	0.000175	0.000767	CcSEcCtD
Buprenorphine—Mental disorder—Bupropion—obesity	0.000175	0.000766	CcSEcCtD
Buprenorphine—Urinary retention—Topiramate—obesity	0.000175	0.000765	CcSEcCtD
Buprenorphine—Anxiety—Orlistat—obesity	0.000175	0.000765	CcSEcCtD
Buprenorphine—Mood swings—Topiramate—obesity	0.000174	0.000762	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000174	0.000762	CcSEcCtD
Buprenorphine—Cough—Sibutramine—obesity	0.000174	0.000762	CcSEcCtD
Buprenorphine—Malnutrition—Bupropion—obesity	0.000174	0.000761	CcSEcCtD
Buprenorphine—Discomfort—Orlistat—obesity	0.000173	0.000759	CcSEcCtD
Buprenorphine—Convulsion—Sibutramine—obesity	0.000173	0.000756	CcSEcCtD
Buprenorphine—CYP3A4—digestive system—obesity	0.000172	0.00993	CbGeAlD
Buprenorphine—Hypertension—Sibutramine—obesity	0.000172	0.000753	CcSEcCtD
Buprenorphine—Dry mouth—Orlistat—obesity	0.000171	0.000751	CcSEcCtD
Buprenorphine—Flatulence—Bupropion—obesity	0.000171	0.00075	CcSEcCtD
Buprenorphine—Dehydration—Topiramate—obesity	0.000171	0.000749	CcSEcCtD
Buprenorphine—CYP3A5—liver—obesity	0.000171	0.00986	CbGeAlD
Buprenorphine—Tension—Bupropion—obesity	0.00017	0.000747	CcSEcCtD
Buprenorphine—Dysgeusia—Bupropion—obesity	0.00017	0.000745	CcSEcCtD
Buprenorphine—Chest pain—Sibutramine—obesity	0.00017	0.000743	CcSEcCtD
Buprenorphine—Arthralgia—Sibutramine—obesity	0.00017	0.000743	CcSEcCtD
Buprenorphine—Myalgia—Sibutramine—obesity	0.00017	0.000743	CcSEcCtD
Buprenorphine—CYP2D6—digestive system—obesity	0.000169	0.00977	CbGeAlD
Buprenorphine—Anxiety—Sibutramine—obesity	0.000169	0.00074	CcSEcCtD
Buprenorphine—Nervousness—Bupropion—obesity	0.000169	0.000739	CcSEcCtD
Buprenorphine—CYP2C9—liver—obesity	0.000168	0.0097	CbGeAlD
Buprenorphine—Oedema—Orlistat—obesity	0.000168	0.000736	CcSEcCtD
Buprenorphine—Anaphylactic shock—Orlistat—obesity	0.000168	0.000736	CcSEcCtD
Buprenorphine—Back pain—Bupropion—obesity	0.000168	0.000736	CcSEcCtD
Buprenorphine—Abdominal pain upper—Topiramate—obesity	0.000168	0.000735	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Topiramate—obesity	0.000168	0.000735	CcSEcCtD
Buprenorphine—Discomfort—Sibutramine—obesity	0.000167	0.000734	CcSEcCtD
Buprenorphine—Muscle spasms—Bupropion—obesity	0.000167	0.000731	CcSEcCtD
Buprenorphine—Infection—Orlistat—obesity	0.000167	0.000731	CcSEcCtD
Buprenorphine—Breast disorder—Topiramate—obesity	0.000166	0.000727	CcSEcCtD
Buprenorphine—Dry mouth—Sibutramine—obesity	0.000166	0.000727	CcSEcCtD
Buprenorphine—Nervous system disorder—Orlistat—obesity	0.000165	0.000722	CcSEcCtD
Buprenorphine—Nasopharyngitis—Topiramate—obesity	0.000164	0.00072	CcSEcCtD
Buprenorphine—Confusional state—Sibutramine—obesity	0.000164	0.000718	CcSEcCtD
Buprenorphine—Vision blurred—Bupropion—obesity	0.000164	0.000717	CcSEcCtD
Buprenorphine—Skin disorder—Orlistat—obesity	0.000163	0.000715	CcSEcCtD
Buprenorphine—Tremor—Bupropion—obesity	0.000163	0.000713	CcSEcCtD
Buprenorphine—Anaphylactic shock—Sibutramine—obesity	0.000163	0.000712	CcSEcCtD
Buprenorphine—Oedema—Sibutramine—obesity	0.000163	0.000712	CcSEcCtD
Buprenorphine—Hyperhidrosis—Orlistat—obesity	0.000162	0.000711	CcSEcCtD
Buprenorphine—Muscular weakness—Topiramate—obesity	0.000162	0.00071	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Topiramate—obesity	0.000162	0.00071	CcSEcCtD
Buprenorphine—Infection—Sibutramine—obesity	0.000161	0.000708	CcSEcCtD
Buprenorphine—Ill-defined disorder—Bupropion—obesity	0.000161	0.000706	CcSEcCtD
Buprenorphine—ABCB1—adrenal cortex—obesity	0.000161	0.00928	CbGeAlD
Buprenorphine—Shock—Sibutramine—obesity	0.00016	0.000701	CcSEcCtD
Buprenorphine—Abdominal distension—Topiramate—obesity	0.00016	0.0007	CcSEcCtD
Buprenorphine—Agitation—Bupropion—obesity	0.00016	0.000699	CcSEcCtD
Buprenorphine—Dysphagia—Topiramate—obesity	0.000159	0.000696	CcSEcCtD
Buprenorphine—Asthma—Topiramate—obesity	0.000159	0.000696	CcSEcCtD
Buprenorphine—Angioedema—Bupropion—obesity	0.000159	0.000695	CcSEcCtD
Buprenorphine—Tachycardia—Sibutramine—obesity	0.000159	0.000695	CcSEcCtD
Buprenorphine—Skin disorder—Sibutramine—obesity	0.000158	0.000692	CcSEcCtD
Buprenorphine—Hyperhidrosis—Sibutramine—obesity	0.000157	0.000689	CcSEcCtD
Buprenorphine—Malaise—Bupropion—obesity	0.000157	0.000686	CcSEcCtD
Buprenorphine—Vertigo—Bupropion—obesity	0.000156	0.000684	CcSEcCtD
Buprenorphine—Syncope—Bupropion—obesity	0.000156	0.000682	CcSEcCtD
Buprenorphine—Anorexia—Sibutramine—obesity	0.000155	0.000679	CcSEcCtD
Buprenorphine—Angina pectoris—Topiramate—obesity	0.000155	0.000678	CcSEcCtD
Buprenorphine—Palpitations—Bupropion—obesity	0.000153	0.000672	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Orlistat—obesity	0.000153	0.000671	CcSEcCtD
Buprenorphine—Bronchitis—Topiramate—obesity	0.000153	0.000669	CcSEcCtD
Buprenorphine—Loss of consciousness—Bupropion—obesity	0.000153	0.000669	CcSEcCtD
Buprenorphine—Abdominal discomfort—Topiramate—obesity	0.000152	0.000667	CcSEcCtD
Buprenorphine—Insomnia—Orlistat—obesity	0.000152	0.000666	CcSEcCtD
Buprenorphine—Hypotension—Sibutramine—obesity	0.000152	0.000666	CcSEcCtD
Buprenorphine—Cough—Bupropion—obesity	0.000151	0.000664	CcSEcCtD
Buprenorphine—Paraesthesia—Orlistat—obesity	0.000151	0.000661	CcSEcCtD
Buprenorphine—Convulsion—Bupropion—obesity	0.00015	0.000659	CcSEcCtD
Buprenorphine—Hypertension—Bupropion—obesity	0.00015	0.000657	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Sibutramine—obesity	0.000148	0.000649	CcSEcCtD
Buprenorphine—Dyspepsia—Orlistat—obesity	0.000148	0.000648	CcSEcCtD
Buprenorphine—Arthralgia—Bupropion—obesity	0.000148	0.000648	CcSEcCtD
Buprenorphine—Chest pain—Bupropion—obesity	0.000148	0.000648	CcSEcCtD
Buprenorphine—Myalgia—Bupropion—obesity	0.000148	0.000648	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Topiramate—obesity	0.000148	0.000647	CcSEcCtD
Buprenorphine—Anxiety—Bupropion—obesity	0.000147	0.000645	CcSEcCtD
Buprenorphine—Insomnia—Sibutramine—obesity	0.000147	0.000644	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000147	0.000643	CcSEcCtD
Buprenorphine—ABCB1—cardiovascular system—obesity	0.000147	0.00847	CbGeAlD
Buprenorphine—Discomfort—Bupropion—obesity	0.000146	0.00064	CcSEcCtD
Buprenorphine—Decreased appetite—Orlistat—obesity	0.000146	0.00064	CcSEcCtD
Buprenorphine—Paraesthesia—Sibutramine—obesity	0.000146	0.00064	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Orlistat—obesity	0.000145	0.000635	CcSEcCtD
Buprenorphine—Dyspnoea—Sibutramine—obesity	0.000145	0.000635	CcSEcCtD
Buprenorphine—Fatigue—Orlistat—obesity	0.000145	0.000635	CcSEcCtD
Buprenorphine—Dry mouth—Bupropion—obesity	0.000145	0.000633	CcSEcCtD
Buprenorphine—Somnolence—Sibutramine—obesity	0.000144	0.000633	CcSEcCtD
Buprenorphine—Weight decreased—Topiramate—obesity	0.000144	0.000629	CcSEcCtD
Buprenorphine—Pain—Orlistat—obesity	0.000144	0.000629	CcSEcCtD
Buprenorphine—Dyspepsia—Sibutramine—obesity	0.000143	0.000627	CcSEcCtD
Buprenorphine—Confusional state—Bupropion—obesity	0.000143	0.000626	CcSEcCtD
Buprenorphine—CYP3A4—endocrine gland—obesity	0.000142	0.00821	CbGeAlD
Buprenorphine—Oedema—Bupropion—obesity	0.000142	0.000621	CcSEcCtD
Buprenorphine—Anaphylactic shock—Bupropion—obesity	0.000142	0.000621	CcSEcCtD
Buprenorphine—Infestation NOS—Topiramate—obesity	0.000142	0.00062	CcSEcCtD
Buprenorphine—Infestation—Topiramate—obesity	0.000142	0.00062	CcSEcCtD
Buprenorphine—Decreased appetite—Sibutramine—obesity	0.000141	0.000619	CcSEcCtD
Buprenorphine—Depression—Topiramate—obesity	0.000141	0.000618	CcSEcCtD
Buprenorphine—Infection—Bupropion—obesity	0.000141	0.000617	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Sibutramine—obesity	0.00014	0.000615	CcSEcCtD
Buprenorphine—CYP2D6—endocrine gland—obesity	0.00014	0.00807	CbGeAlD
Buprenorphine—Shock—Bupropion—obesity	0.000139	0.000611	CcSEcCtD
Buprenorphine—Constipation—Sibutramine—obesity	0.000139	0.000609	CcSEcCtD
Buprenorphine—Pain—Sibutramine—obesity	0.000139	0.000609	CcSEcCtD
Buprenorphine—Nervous system disorder—Bupropion—obesity	0.000139	0.000609	CcSEcCtD
Buprenorphine—Feeling abnormal—Orlistat—obesity	0.000138	0.000606	CcSEcCtD
Buprenorphine—Tachycardia—Bupropion—obesity	0.000138	0.000606	CcSEcCtD
Buprenorphine—Skin disorder—Bupropion—obesity	0.000138	0.000603	CcSEcCtD
Buprenorphine—Urinary tract infection—Topiramate—obesity	0.000138	0.000603	CcSEcCtD
Buprenorphine—Conjunctivitis—Topiramate—obesity	0.000138	0.000603	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Orlistat—obesity	0.000137	0.000602	CcSEcCtD
Buprenorphine—Hyperhidrosis—Bupropion—obesity	0.000137	0.0006	CcSEcCtD
Buprenorphine—Anorexia—Bupropion—obesity	0.000135	0.000592	CcSEcCtD
Buprenorphine—Feeling abnormal—Sibutramine—obesity	0.000134	0.000587	CcSEcCtD
Buprenorphine—Urticaria—Orlistat—obesity	0.000133	0.000585	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Sibutramine—obesity	0.000133	0.000582	CcSEcCtD
Buprenorphine—Sinusitis—Topiramate—obesity	0.000133	0.000582	CcSEcCtD
Buprenorphine—Abdominal pain—Orlistat—obesity	0.000133	0.000582	CcSEcCtD
Buprenorphine—Body temperature increased—Orlistat—obesity	0.000133	0.000582	CcSEcCtD
Buprenorphine—Hypotension—Bupropion—obesity	0.000132	0.00058	CcSEcCtD
Buprenorphine—ABCB1—pituitary gland—obesity	0.00013	0.0075	CbGeAlD
Buprenorphine—Bradycardia—Topiramate—obesity	0.000129	0.000567	CcSEcCtD
Buprenorphine—ABCB1—adipose tissue—obesity	0.000129	0.00747	CbGeAlD
Buprenorphine—Urticaria—Sibutramine—obesity	0.000129	0.000566	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Bupropion—obesity	0.000129	0.000566	CcSEcCtD
Buprenorphine—Abdominal pain—Sibutramine—obesity	0.000128	0.000563	CcSEcCtD
Buprenorphine—Body temperature increased—Sibutramine—obesity	0.000128	0.000563	CcSEcCtD
Buprenorphine—Insomnia—Bupropion—obesity	0.000128	0.000562	CcSEcCtD
Buprenorphine—CYP3A4—liver—obesity	0.000128	0.0074	CbGeAlD
Buprenorphine—Rhinitis—Topiramate—obesity	0.000127	0.000558	CcSEcCtD
Buprenorphine—Paraesthesia—Bupropion—obesity	0.000127	0.000558	CcSEcCtD
Buprenorphine—Hypoaesthesia—Topiramate—obesity	0.000126	0.000554	CcSEcCtD
Buprenorphine—Hallucination—Topiramate—obesity	0.000126	0.000554	CcSEcCtD
Buprenorphine—Dyspnoea—Bupropion—obesity	0.000126	0.000554	CcSEcCtD
Buprenorphine—Pharyngitis—Topiramate—obesity	0.000126	0.000553	CcSEcCtD
Buprenorphine—CYP2D6—liver—obesity	0.000126	0.00728	CbGeAlD
Buprenorphine—Somnolence—Bupropion—obesity	0.000126	0.000552	CcSEcCtD
Buprenorphine—Urinary tract disorder—Topiramate—obesity	0.000125	0.00055	CcSEcCtD
Buprenorphine—Oedema peripheral—Topiramate—obesity	0.000125	0.000549	CcSEcCtD
Buprenorphine—Connective tissue disorder—Topiramate—obesity	0.000125	0.000547	CcSEcCtD
Buprenorphine—Dyspepsia—Bupropion—obesity	0.000125	0.000547	CcSEcCtD
Buprenorphine—Urethral disorder—Topiramate—obesity	0.000125	0.000546	CcSEcCtD
Buprenorphine—Hypersensitivity—Orlistat—obesity	0.000124	0.000542	CcSEcCtD
Buprenorphine—Decreased appetite—Bupropion—obesity	0.000123	0.00054	CcSEcCtD
Buprenorphine—Visual impairment—Topiramate—obesity	0.000122	0.000537	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Bupropion—obesity	0.000122	0.000536	CcSEcCtD
Buprenorphine—Fatigue—Bupropion—obesity	0.000122	0.000535	CcSEcCtD
Buprenorphine—ABCB1—digestive system—obesity	0.000122	0.00703	CbGeAlD
Buprenorphine—Constipation—Bupropion—obesity	0.000121	0.000531	CcSEcCtD
Buprenorphine—Pain—Bupropion—obesity	0.000121	0.000531	CcSEcCtD
Buprenorphine—Asthenia—Orlistat—obesity	0.00012	0.000528	CcSEcCtD
Buprenorphine—Hypersensitivity—Sibutramine—obesity	0.00012	0.000525	CcSEcCtD
Buprenorphine—Pruritus—Orlistat—obesity	0.000119	0.000521	CcSEcCtD
Buprenorphine—Eye disorder—Topiramate—obesity	0.000119	0.00052	CcSEcCtD
Buprenorphine—Tinnitus—Topiramate—obesity	0.000118	0.000519	CcSEcCtD
Buprenorphine—Flushing—Topiramate—obesity	0.000118	0.000517	CcSEcCtD
Buprenorphine—Cardiac disorder—Topiramate—obesity	0.000118	0.000517	CcSEcCtD
Buprenorphine—Feeling abnormal—Bupropion—obesity	0.000117	0.000512	CcSEcCtD
Buprenorphine—Asthenia—Sibutramine—obesity	0.000117	0.000511	CcSEcCtD
Buprenorphine—ABCB1—adrenal gland—obesity	0.000116	0.0067	CbGeAlD
Buprenorphine—Gastrointestinal pain—Bupropion—obesity	0.000116	0.000508	CcSEcCtD
Buprenorphine—Angiopathy—Topiramate—obesity	0.000115	0.000505	CcSEcCtD
Buprenorphine—Pruritus—Sibutramine—obesity	0.000115	0.000504	CcSEcCtD
Buprenorphine—Diarrhoea—Orlistat—obesity	0.000115	0.000504	CcSEcCtD
Buprenorphine—Immune system disorder—Topiramate—obesity	0.000115	0.000503	CcSEcCtD
Buprenorphine—Mediastinal disorder—Topiramate—obesity	0.000115	0.000502	CcSEcCtD
Buprenorphine—Chills—Topiramate—obesity	0.000114	0.0005	CcSEcCtD
Buprenorphine—Urticaria—Bupropion—obesity	0.000113	0.000493	CcSEcCtD
Buprenorphine—Abdominal pain—Bupropion—obesity	0.000112	0.000491	CcSEcCtD
Buprenorphine—Body temperature increased—Bupropion—obesity	0.000112	0.000491	CcSEcCtD
Buprenorphine—Mental disorder—Topiramate—obesity	0.000111	0.000488	CcSEcCtD
Buprenorphine—Diarrhoea—Sibutramine—obesity	0.000111	0.000487	CcSEcCtD
Buprenorphine—Dizziness—Orlistat—obesity	0.000111	0.000487	CcSEcCtD
Buprenorphine—Erythema—Topiramate—obesity	0.000111	0.000485	CcSEcCtD
Buprenorphine—Malnutrition—Topiramate—obesity	0.000111	0.000485	CcSEcCtD
Buprenorphine—Flatulence—Topiramate—obesity	0.000109	0.000478	CcSEcCtD
Buprenorphine—Tension—Topiramate—obesity	0.000109	0.000476	CcSEcCtD
Buprenorphine—Dysgeusia—Topiramate—obesity	0.000108	0.000475	CcSEcCtD
Buprenorphine—Dizziness—Sibutramine—obesity	0.000107	0.000471	CcSEcCtD
Buprenorphine—Nervousness—Topiramate—obesity	0.000107	0.000471	CcSEcCtD
Buprenorphine—Back pain—Topiramate—obesity	0.000107	0.000469	CcSEcCtD
Buprenorphine—Vomiting—Orlistat—obesity	0.000107	0.000468	CcSEcCtD
Buprenorphine—Muscle spasms—Topiramate—obesity	0.000106	0.000466	CcSEcCtD
Buprenorphine—Rash—Orlistat—obesity	0.000106	0.000464	CcSEcCtD
Buprenorphine—Dermatitis—Orlistat—obesity	0.000106	0.000464	CcSEcCtD
Buprenorphine—Headache—Orlistat—obesity	0.000105	0.000461	CcSEcCtD
Buprenorphine—Hypersensitivity—Bupropion—obesity	0.000104	0.000457	CcSEcCtD
Buprenorphine—Vision blurred—Topiramate—obesity	0.000104	0.000457	CcSEcCtD
Buprenorphine—Tremor—Topiramate—obesity	0.000104	0.000454	CcSEcCtD
Buprenorphine—Vomiting—Sibutramine—obesity	0.000103	0.000453	CcSEcCtD
Buprenorphine—Ill-defined disorder—Topiramate—obesity	0.000103	0.00045	CcSEcCtD
Buprenorphine—Rash—Sibutramine—obesity	0.000102	0.000449	CcSEcCtD
Buprenorphine—Dermatitis—Sibutramine—obesity	0.000102	0.000449	CcSEcCtD
Buprenorphine—Headache—Sibutramine—obesity	0.000102	0.000446	CcSEcCtD
Buprenorphine—Asthenia—Bupropion—obesity	0.000102	0.000446	CcSEcCtD
Buprenorphine—Agitation—Topiramate—obesity	0.000102	0.000445	CcSEcCtD
Buprenorphine—ABCB1—endocrine gland—obesity	0.000101	0.00581	CbGeAlD
Buprenorphine—Pruritus—Bupropion—obesity	0.0001	0.000439	CcSEcCtD
Buprenorphine—Nausea—Orlistat—obesity	9.97e-05	0.000437	CcSEcCtD
Buprenorphine—Malaise—Topiramate—obesity	9.97e-05	0.000437	CcSEcCtD
Buprenorphine—Vertigo—Topiramate—obesity	9.94e-05	0.000435	CcSEcCtD
Buprenorphine—Syncope—Topiramate—obesity	9.92e-05	0.000435	CcSEcCtD
Buprenorphine—Palpitations—Topiramate—obesity	9.77e-05	0.000428	CcSEcCtD
Buprenorphine—Loss of consciousness—Topiramate—obesity	9.72e-05	0.000426	CcSEcCtD
Buprenorphine—Diarrhoea—Bupropion—obesity	9.69e-05	0.000425	CcSEcCtD
Buprenorphine—Nausea—Sibutramine—obesity	9.65e-05	0.000423	CcSEcCtD
Buprenorphine—Cough—Topiramate—obesity	9.65e-05	0.000423	CcSEcCtD
Buprenorphine—Convulsion—Topiramate—obesity	9.58e-05	0.00042	CcSEcCtD
Buprenorphine—Hypertension—Topiramate—obesity	9.55e-05	0.000418	CcSEcCtD
Buprenorphine—Myalgia—Topiramate—obesity	9.42e-05	0.000413	CcSEcCtD
Buprenorphine—Chest pain—Topiramate—obesity	9.42e-05	0.000413	CcSEcCtD
Buprenorphine—Arthralgia—Topiramate—obesity	9.42e-05	0.000413	CcSEcCtD
Buprenorphine—Anxiety—Topiramate—obesity	9.38e-05	0.000411	CcSEcCtD
Buprenorphine—Dizziness—Bupropion—obesity	9.37e-05	0.000411	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.35e-05	0.00041	CcSEcCtD
Buprenorphine—Discomfort—Topiramate—obesity	9.3e-05	0.000408	CcSEcCtD
Buprenorphine—Dry mouth—Topiramate—obesity	9.21e-05	0.000404	CcSEcCtD
Buprenorphine—Confusional state—Topiramate—obesity	9.1e-05	0.000399	CcSEcCtD
Buprenorphine—ABCB1—liver—obesity	9.07e-05	0.00524	CbGeAlD
Buprenorphine—Oedema—Topiramate—obesity	9.03e-05	0.000396	CcSEcCtD
Buprenorphine—Vomiting—Bupropion—obesity	9.01e-05	0.000395	CcSEcCtD
Buprenorphine—Infection—Topiramate—obesity	8.97e-05	0.000393	CcSEcCtD
Buprenorphine—Rash—Bupropion—obesity	8.93e-05	0.000392	CcSEcCtD
Buprenorphine—Dermatitis—Bupropion—obesity	8.92e-05	0.000391	CcSEcCtD
Buprenorphine—Shock—Topiramate—obesity	8.88e-05	0.000389	CcSEcCtD
Buprenorphine—Headache—Bupropion—obesity	8.88e-05	0.000389	CcSEcCtD
Buprenorphine—Nervous system disorder—Topiramate—obesity	8.85e-05	0.000388	CcSEcCtD
Buprenorphine—Tachycardia—Topiramate—obesity	8.81e-05	0.000386	CcSEcCtD
Buprenorphine—Skin disorder—Topiramate—obesity	8.77e-05	0.000384	CcSEcCtD
Buprenorphine—Hyperhidrosis—Topiramate—obesity	8.73e-05	0.000382	CcSEcCtD
Buprenorphine—Anorexia—Topiramate—obesity	8.6e-05	0.000377	CcSEcCtD
Buprenorphine—Hypotension—Topiramate—obesity	8.43e-05	0.00037	CcSEcCtD
Buprenorphine—Nausea—Bupropion—obesity	8.42e-05	0.000369	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Topiramate—obesity	8.22e-05	0.00036	CcSEcCtD
Buprenorphine—Insomnia—Topiramate—obesity	8.16e-05	0.000358	CcSEcCtD
Buprenorphine—Paraesthesia—Topiramate—obesity	8.11e-05	0.000355	CcSEcCtD
Buprenorphine—Dyspnoea—Topiramate—obesity	8.05e-05	0.000353	CcSEcCtD
Buprenorphine—Somnolence—Topiramate—obesity	8.02e-05	0.000352	CcSEcCtD
Buprenorphine—Dyspepsia—Topiramate—obesity	7.95e-05	0.000348	CcSEcCtD
Buprenorphine—Decreased appetite—Topiramate—obesity	7.85e-05	0.000344	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Topiramate—obesity	7.79e-05	0.000342	CcSEcCtD
Buprenorphine—Fatigue—Topiramate—obesity	7.78e-05	0.000341	CcSEcCtD
Buprenorphine—Pain—Topiramate—obesity	7.72e-05	0.000338	CcSEcCtD
Buprenorphine—Constipation—Topiramate—obesity	7.72e-05	0.000338	CcSEcCtD
Buprenorphine—Feeling abnormal—Topiramate—obesity	7.44e-05	0.000326	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Topiramate—obesity	7.38e-05	0.000323	CcSEcCtD
Buprenorphine—Urticaria—Topiramate—obesity	7.17e-05	0.000314	CcSEcCtD
Buprenorphine—Abdominal pain—Topiramate—obesity	7.14e-05	0.000313	CcSEcCtD
Buprenorphine—Body temperature increased—Topiramate—obesity	7.14e-05	0.000313	CcSEcCtD
Buprenorphine—Hypersensitivity—Topiramate—obesity	6.65e-05	0.000291	CcSEcCtD
Buprenorphine—Asthenia—Topiramate—obesity	6.48e-05	0.000284	CcSEcCtD
Buprenorphine—Pruritus—Topiramate—obesity	6.39e-05	0.00028	CcSEcCtD
Buprenorphine—Diarrhoea—Topiramate—obesity	6.18e-05	0.000271	CcSEcCtD
Buprenorphine—Dizziness—Topiramate—obesity	5.97e-05	0.000262	CcSEcCtD
Buprenorphine—Vomiting—Topiramate—obesity	5.74e-05	0.000252	CcSEcCtD
Buprenorphine—Rash—Topiramate—obesity	5.69e-05	0.000249	CcSEcCtD
Buprenorphine—Dermatitis—Topiramate—obesity	5.69e-05	0.000249	CcSEcCtD
Buprenorphine—Headache—Topiramate—obesity	5.65e-05	0.000248	CcSEcCtD
Buprenorphine—Nausea—Topiramate—obesity	5.36e-05	0.000235	CcSEcCtD
Buprenorphine—CYP2D6—Metabolism—PPARGC1A—obesity	2.65e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—obesity	2.65e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK8—obesity	2.65e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MTOR—obesity	2.65e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PIK3CB—obesity	2.65e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AKT1—obesity	2.64e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMOX1—obesity	2.64e-06	1.52e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.64e-06	1.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GNB3—obesity	2.63e-06	1.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARGC1A—obesity	2.63e-06	1.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LPL—obesity	2.62e-06	1.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMOX1—obesity	2.62e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCG—obesity	2.61e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC2A4—obesity	2.61e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NAMPT—obesity	2.6e-06	1.5e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARA—obesity	2.6e-06	1.5e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LIPC—obesity	2.59e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCK—obesity	2.59e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GNAS—obesity	2.58e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYCS—obesity	2.57e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOC3—obesity	2.57e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CG—obesity	2.57e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MYC—obesity	2.56e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LPL—obesity	2.56e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPX1—obesity	2.56e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GNAS—obesity	2.56e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—obesity	2.56e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOB—obesity	2.53e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGT1—obesity	2.52e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT1—obesity	2.52e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AGT—obesity	2.52e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOB—obesity	2.51e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPX1—obesity	2.5e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PIK3CA—obesity	2.5e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CETP—obesity	2.5e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PIK3CB—obesity	2.5e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CD36—obesity	2.49e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NCOA1—obesity	2.49e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—obesity	2.48e-06	1.43e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—obesity	2.47e-06	1.43e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SDC1—obesity	2.47e-06	1.43e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—obesity	2.46e-06	1.42e-05	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AKT1—obesity	2.46e-06	1.42e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP19A1—obesity	2.45e-06	1.42e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—STK11—obesity	2.45e-06	1.42e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—obesity	2.44e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAV1—obesity	2.44e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOA1—obesity	2.44e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CD36—obesity	2.43e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—INS—obesity	2.43e-06	1.4e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AKR1C3—obesity	2.43e-06	1.4e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—STAT3—obesity	2.42e-06	1.4e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—obesity	2.42e-06	1.4e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LPL—obesity	2.41e-06	1.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LPL—obesity	2.39e-06	1.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SCARB1—obesity	2.39e-06	1.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—obesity	2.36e-06	1.37e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPX1—obesity	2.36e-06	1.36e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPX1—obesity	2.33e-06	1.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.33e-06	1.35e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SREBF1—obesity	2.32e-06	1.34e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARA—obesity	2.32e-06	1.34e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—obesity	2.31e-06	1.33e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—obesity	2.3e-06	1.33e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CD36—obesity	2.29e-06	1.33e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—COMT—obesity	2.28e-06	1.32e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CD36—obesity	2.27e-06	1.31e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARA—obesity	2.26e-06	1.31e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CD—obesity	2.26e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT2—obesity	2.26e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MYC—obesity	2.25e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARGC1A—obesity	2.25e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GNB3—obesity	2.25e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AGT—obesity	2.25e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—obesity	2.24e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK8—obesity	2.24e-06	1.29e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMOX1—obesity	2.24e-06	1.29e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AKT1—obesity	2.23e-06	1.29e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—obesity	2.23e-06	1.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CG—obesity	2.22e-06	1.29e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—FASN—obesity	2.21e-06	1.28e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—obesity	2.2e-06	1.27e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—BCHE—obesity	2.2e-06	1.27e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AGT—obesity	2.19e-06	1.27e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GNAS—obesity	2.19e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAV1—obesity	2.18e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PIK3CA—obesity	2.18e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOA1—obesity	2.17e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—obesity	2.17e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—obesity	2.15e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—obesity	2.15e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—obesity	2.15e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOB—obesity	2.14e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARA—obesity	2.13e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3R1—obesity	2.13e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—obesity	2.13e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAV1—obesity	2.13e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOA1—obesity	2.12e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2E1—obesity	2.12e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—obesity	2.12e-06	1.22e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARA—obesity	2.11e-06	1.22e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—INS—obesity	2.11e-06	1.22e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NQO1—obesity	2.1e-06	1.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.08e-06	1.2e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AGT—obesity	2.07e-06	1.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AGT—obesity	2.05e-06	1.18e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STAT3—obesity	2.05e-06	1.18e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LPL—obesity	2.05e-06	1.18e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—AKT1—obesity	2.04e-06	1.18e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—obesity	2.02e-06	1.17e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCG—obesity	2.01e-06	1.16e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC2A4—obesity	2.01e-06	1.16e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—obesity	2.01e-06	1.16e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAV1—obesity	2e-06	1.16e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOA1—obesity	2e-06	1.16e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPX1—obesity	2e-06	1.15e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAV1—obesity	1.99e-06	1.15e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CG—obesity	1.99e-06	1.15e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYCS—obesity	1.99e-06	1.15e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOA1—obesity	1.98e-06	1.15e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PIK3CA—obesity	1.97e-06	1.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CB—obesity	1.97e-06	1.14e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CD—obesity	1.96e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—obesity	1.95e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT1—obesity	1.95e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGT1—obesity	1.95e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CD36—obesity	1.94e-06	1.12e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CG—obesity	1.94e-06	1.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—obesity	1.93e-06	1.12e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—obesity	1.93e-06	1.11e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NCOA1—obesity	1.92e-06	1.11e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—obesity	1.92e-06	1.11e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PIK3CA—obesity	1.91e-06	1.1e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MYC—obesity	1.9e-06	1.1e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.9e-06	1.1e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—obesity	1.9e-06	1.1e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP19A1—obesity	1.89e-06	1.09e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—STK11—obesity	1.89e-06	1.09e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—obesity	1.89e-06	1.09e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—INS—obesity	1.88e-06	1.09e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—obesity	1.87e-06	1.08e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—obesity	1.85e-06	1.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3R1—obesity	1.85e-06	1.07e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—obesity	1.84e-06	1.07e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—obesity	1.84e-06	1.06e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—INS—obesity	1.83e-06	1.06e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CG—obesity	1.83e-06	1.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CG—obesity	1.81e-06	1.05e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARA—obesity	1.81e-06	1.04e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AKT1—obesity	1.78e-06	1.03e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—obesity	1.76e-06	1.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—COMT—obesity	1.76e-06	1.02e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AGT—obesity	1.75e-06	1.01e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—obesity	1.75e-06	1.01e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CD—obesity	1.75e-06	1.01e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—obesity	1.74e-06	1e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARGC1A—obesity	1.73e-06	1e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GNB3—obesity	1.73e-06	1e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—INS—obesity	1.73e-06	9.99e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMOX1—obesity	1.73e-06	9.97e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—obesity	1.72e-06	9.96e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—obesity	1.72e-06	9.95e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—obesity	1.71e-06	9.9e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—INS—obesity	1.71e-06	9.9e-06	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CB—obesity	1.7e-06	9.85e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CD—obesity	1.7e-06	9.84e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAV1—obesity	1.7e-06	9.81e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOA1—obesity	1.69e-06	9.79e-06	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—obesity	1.69e-06	9.77e-06	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—obesity	1.69e-06	9.76e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GNAS—obesity	1.69e-06	9.75e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—obesity	1.68e-06	9.72e-06	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PIK3CA—obesity	1.67e-06	9.67e-06	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PIK3CA—obesity	1.66e-06	9.59e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOB—obesity	1.65e-06	9.55e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—obesity	1.65e-06	9.52e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3R1—obesity	1.65e-06	9.52e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.62e-06	9.37e-06	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PIK3CA—obesity	1.61e-06	9.32e-06	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—AKT1—obesity	1.61e-06	9.31e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3R1—obesity	1.61e-06	9.29e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—obesity	1.61e-06	9.29e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CD—obesity	1.61e-06	9.27e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CD—obesity	1.59e-06	9.19e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—obesity	1.58e-06	9.16e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPL—obesity	1.58e-06	9.12e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—obesity	1.57e-06	9.08e-06	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AKT1—obesity	1.56e-06	9.01e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CG—obesity	1.55e-06	8.94e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPX1—obesity	1.54e-06	8.9e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CB—obesity	1.52e-06	8.79e-06	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PIK3CA—obesity	1.52e-06	8.79e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3R1—obesity	1.52e-06	8.76e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—obesity	1.52e-06	8.76e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—obesity	1.51e-06	8.71e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—obesity	1.5e-06	8.68e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3R1—obesity	1.5e-06	8.68e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CD36—obesity	1.5e-06	8.66e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—obesity	1.49e-06	8.63e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CB—obesity	1.48e-06	8.58e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—obesity	1.47e-06	8.51e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—obesity	1.47e-06	8.5e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—INS—obesity	1.46e-06	8.46e-06	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—obesity	1.43e-06	8.25e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—obesity	1.42e-06	8.21e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CB—obesity	1.4e-06	8.08e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARA—obesity	1.39e-06	8.05e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CB—obesity	1.39e-06	8.01e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—obesity	1.39e-06	8.01e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—obesity	1.37e-06	7.94e-06	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—AKT1—obesity	1.37e-06	7.9e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CD—obesity	1.36e-06	7.86e-06	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—AKT1—obesity	1.36e-06	7.83e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AGT—obesity	1.35e-06	7.8e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—obesity	1.34e-06	7.76e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—obesity	1.32e-06	7.64e-06	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AKT1—obesity	1.32e-06	7.61e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAV1—obesity	1.31e-06	7.57e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOA1—obesity	1.31e-06	7.56e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—obesity	1.28e-06	7.42e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3R1—obesity	1.28e-06	7.42e-06	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AKT1—obesity	1.24e-06	7.18e-06	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CA—obesity	1.2e-06	6.93e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CG—obesity	1.19e-06	6.9e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CB—obesity	1.19e-06	6.85e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—obesity	1.17e-06	6.79e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—obesity	1.15e-06	6.66e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—obesity	1.14e-06	6.57e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—INS—obesity	1.13e-06	6.53e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CD—obesity	1.05e-06	6.06e-06	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CA—obesity	1.04e-06	6e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—obesity	1.04e-06	5.99e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3R1—obesity	9.91e-07	5.73e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—obesity	9.91e-07	5.73e-06	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AKT1—obesity	9.8e-07	5.66e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CA—obesity	9.27e-07	5.36e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CB—obesity	9.15e-07	5.29e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—obesity	9.07e-07	5.24e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CA—obesity	9.05e-07	5.23e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CA—obesity	8.53e-07	4.93e-06	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AKT1—obesity	8.49e-07	4.9e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CA—obesity	8.46e-07	4.89e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AKT1—obesity	7.58e-07	4.38e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AKT1—obesity	7.4e-07	4.27e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CA—obesity	7.23e-07	4.17e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AKT1—obesity	6.97e-07	4.03e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AKT1—obesity	6.91e-07	3.99e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AKT1—obesity	5.9e-07	3.41e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CA—obesity	5.58e-07	3.22e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AKT1—obesity	4.56e-07	2.63e-06	CbGpPWpGaD
